Serplulimab
| FIELD OF APPLICATION | DETAILS |
|---|---|
| Generic Name | Serplulimab |
| Active Ingredient | Serplulimab |
| Drug Category | Cancer |
| Drug Class | First-line therapy, Prophylactic, preventive therapy, Palliative treatment, Immunosuppressive therapy, Targeted therapy |
| Route of Administration | Intravenous Injection |
| FDA Approval Status | Not Approved |
Serplulimab Overview
Serplulimab is a highly advanced medication utilized within the Cancer department to treat specific aggressive lung tumors. It functions as a powerful Biologic and Immunotherapy designed to help the human immune system identify and destroy malignant cancer cells.
What Is Serplulimab & How Does It Work?
Serplulimab is a specialized Targeted Therapy known as an immune checkpoint inhibitor. In a healthy body, the immune system uses T cells to find and eliminate abnormal cells, but cancer cells often hide by expressing a protein called PD-L1 that effectively turns these T cells off. By blocking the PD-1 receptor on the T cells, Serplulimab prevents the tumor from deactivating them, successfully waking up the immune system so it can actively attack the extensive stage of small cell lung cancer.
Is Serplulimab FDA Approved?
Serplulimab is not currently approved by the Food and Drug Administration for use within the United States. However, it received official regulatory approval from the European Commission in February 2025 and is also authorized for use in several Southeast Asian countries.
What Is Serplulimab Used For?
- It is utilized in the Cancer department as a first line treatment for adult patients diagnosed with extensive stage small cell lung cancer.
- The medication is strictly administered in combination with the standard chemotherapy drugs carboplatin and etoposide.
- It serves as a vital Immunotherapy to help manage tumors that have already spread widely from the lungs to other parts of the body.
Before Taking Serplulimab: Contraindications & Precautions
Medical specialists must carefully evaluate your overall health and baseline immune function before starting this powerful medication. Because the drug strongly stimulates the immune system, certain underlying health conditions can make this treatment exceptionally unsafe.
Who Should Not Take Serplulimab?
- Patients with a known severe allergy to Serplulimab or its inactive liquid ingredients.
- Individuals suffering from active, severe autoimmune diseases that require treatment with systemic immunosuppressive drugs.
- Patients who have recently undergone organ transplants, as the awakened immune system could attack and reject the new organ.
Serplulimab, Pregnancy & Fertility
- This medication can cause serious fetal harm because the highly activated immune system may attack a developing baby.
- Women of childbearing age must use highly effective contraception during treatment and for several months after receiving their last dose.
- Nursing mothers should completely stop breastfeeding during treatment to protect the infant from potential drug exposure.
Tell Your Doctor Before Taking Serplulimab
- Disclose any history of chronic immune system disorders like rheumatoid arthritis, lupus, or Crohn’s disease.
- Inform your primary oncologist if you have a history of chronic liver disease or severe lung inflammation.
- Provide a full list of your current daily medications, especially corticosteroids that could reduce the treatment’s overall effectiveness.
Serplulimab: Dosage & Administration
The exact dosing schedule for this Biologic is calculated by your specialized oncology team based on standardized international clinical protocols. It must be administered in a hospital setting equipped to handle potential rapid infusion reactions.
Standard Serplulimab Dosing
- The recommended dose is typically given at regular intervals, such as every three weeks, based on your body weight or a fixed standard dose calculation.
- During the initial phases, it is administered on the exact same day as your companion chemotherapy drugs.
- Following the completion of the chemotherapy phase, patients often continue receiving Serplulimab alone as a long term maintenance therapy.
How Serplulimab Is Administered
- The medication is delivered directly into a vein through a steady intravenous infusion.
- Healthcare professionals carefully dilute the concentrated liquid and administer it slowly over a period of thirty to sixty minutes.
- You will remain under close medical observation during and shortly after the infusion to ensure you do not develop an acute allergic reaction.
Serplulimab Clinical Efficacy & Research
Clinical studies confirm that Serplulimab, when combined with standard chemotherapy, provides a significant improvement in overall survival for patients facing extensive stage small cell lung cancer. By acting as a highly effective Targeted Therapy, it helps shrink tumors and delays the progression of the disease much better than traditional chemotherapy alone. This sustained immune response offers a meaningful extension of life, allowing patients to maintain their overall quality of life for a significantly longer period.
Serplulimab Side Effects & Safety Profile
This medication does not have an FDA Black Box Warning. It does, however, carry critical clinical warnings regarding severe immune mediated tissue inflammation that requires prompt medical attention.
Like all potent cancer treatments, this medication can trigger a variety of severe side effects as your body adjusts to the intense immune activity. You will be closely monitored by your specialized medical team to quickly identify and manage any adverse physical reactions.
Serplulimab Common Side Effects
- Persistent daily fatigue and a general sense of profound physical weakness.
- Mild to moderate nausea, occasional vomiting, or a noticeable decrease in daily appetite.
- Skin reactions such as superficial dryness, mild itching, or a spreading rash.
- Muscle stiffness, generalized joint pain, or aching bone discomfort.
Serious Serplulimab Adverse Events
- Immune mediated pneumonitis, which is severe lung inflammation causing shortness of breath and sharp chest pain.
- Immune mediated colitis leading to severe abdominal cramping and uncontrolled severe diarrhea.
- Immune mediated hepatitis resulting in dangerous liver damage, yellowing eyes, and dark colored urine.
- Severe hormone imbalances caused by sudden immune attacks on the thyroid or pituitary glands.
Managing Serplulimab Side Effects
If you experience severe diarrhea, sudden breathing difficulties, or profound weakness, contact your oncology team immediately. Doctors typically manage severe immune reactions by temporarily pausing the Immunotherapy and prescribing high doses of corticosteroids to effectively calm the overactive immune system.
Serplulimab: Interactions & What to Avoid
Certain common medications and daily lifestyle factors can interfere with how this drug works or severely increase your risk of dangerous side effects. It is highly critical to share everything you currently take with your oncologist to prevent harmful chemical interactions.
Serplulimab Interactions
- Systemic corticosteroids like prednisone can suppress the immune system and stop the medication from working effectively against the tumor.
- Other targeted immunosuppressant medications used for autoimmune diseases directly counteract the intended mechanism of this treatment.
- Live virus vaccines must be strictly avoided, as your altered immune system might develop a severe infection directly from the live vaccine.
Serplulimab Food & Alcohol
- Avoid excessive alcohol intake, as it puts extra stress on your liver and can easily mask or worsen potential immune liver toxicity.
- Do not take unregulated herbal immune boosting supplements, as they can cause unpredictable and dangerous immune system reactions during therapy.
Serplulimab: Missed Dose, Overdose & Storage
Sticking tightly to your prescribed hospital infusion schedule is vital for controlling your aggressive cancer effectively. Since the medication is handled entirely by qualified healthcare professionals, issues regarding physical storage and missed doses are managed directly by the clinic.
Missed Dose of Serplulimab
If you miss a scheduled hospital infusion appointment, contact your oncology clinic immediately to reschedule. The medical staff will carefully adjust your treatment timeline to ensure you receive the medication safely without stacking the doses too closely.
Serplulimab Overdose & Emergency
An accidental overdose is extremely rare because the drug is meticulously calculated and administered by specialized nurses. If an overdose somehow occurs, you will be monitored closely in the hospital and treated with systemic corticosteroids to rapidly reverse any exaggerated immune reactions.
How to Store Serplulimab
Patients do not ever handle or store this medication at their home. Hospital pharmacies keep the drug securely locked in a temperature controlled refrigerator between 2 degrees and 8 degrees Celsius.
Serplulimab: Patient Management & Monitoring
Thorough clinical monitoring is absolutely necessary to ensure you are safely tolerating this advanced immune treatment. Your medical team will perform regular diagnostic tests to track your internal organ function and overall tumor response.
Tests Before Starting Serplulimab
- Comprehensive blood tests to check baseline liver function, kidney health, and complete red and white blood counts.
- Hormone panels, particularly deep thyroid tests, to establish a healthy baseline before the immune treatment begins.
- High resolution chest imaging to measure the exact physical size and location of the lung tumors.
Monitoring During Serplulimab Treatment
- Routine blood work before every single hospital infusion to catch early hidden signs of internal organ inflammation.
- Periodic CT scans to visibly confirm the tumors are shrinking or remaining stable during the treatment cycle.
- Continuous clinical checkups to evaluate your lung breathing, daily energy levels, and normal digestive health.
Serplulimab Do’s and Don’ts
- Do drink plenty of water every single day to help your kidneys safely flush out the companion chemotherapy drugs.
- Do report even minor changes in your daily health, like a new persistent cough or mild diarrhea, to your doctor right away.
- Don’t get any standard vaccines without getting explicit medical permission from your primary oncologist first.
- Don’t start taking any new over the counter medications or vitamins without clearance from your dedicated medical team.
Frequently Asked Questions
How is Serplulimab different from regular chemotherapy?
Regular chemotherapy directly kills rapidly dividing cells inside the body, while this medication is an immunotherapy that actively trains your own immune system to recognize and attack the cancer naturally.
Will I lose my hair while receiving this treatment?
This specific medication itself does not usually cause any hair loss. However, you will likely lose your hair because it is given alongside traditional chemotherapy drugs that do cause hair follicles to drop.
How long will I have to take this medication?
Treatment length varies heavily by patient, but many continue receiving the drug as a maintenance therapy for up to two years if the cancer remains completely stable.
Can this drug cure my extensive stage lung cancer?
Extensive stage small cell lung cancer is not currently considered curable by modern medicine. This medication is a life extending treatment meant to control tumor growth and vastly improve your overall survival time.
Why do I need so many blood tests during treatment?
The medication constantly activates your immune system, which can sometimes mistakenly attack healthy organs like your liver or kidneys. Blood tests help doctors spot this internal inflammation long before you actually feel sick.
What should I do if I start coughing at home?
A new or worsening cough can be an early sign of severe lung inflammation caused by the activated immune system. You should contact your cancer clinic immediately for a medical evaluation.
Is it safe to be around people who are sick?
Because you are taking this drug combined with heavy chemotherapy, your body is temporarily weaker at fighting everyday germs and viruses. You should always avoid close contact with anyone who has a contagious illness.
References
- European Medicines Agency (EMA) – Hetronifly (serplulimab) authorization and clinical data
- National Cancer Institute (NCI) – Cancer Treatment Protocols
Legal Disclaimer
The information provided is for educational and informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider at Liv Hospital or your local clinic before starting or stopping any medication.



